The natural course of disease following HIV-1 infection in Dar es Salaam, Tanzania: A study among hotel workers relating clinical events to CD4+ T-lymphocyte counts

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 6-7, 2004, Pages 466-473

  Bakari, Muhammad ^a   Urassa, Willy ^a   Pallangyo, Kisali ^a   Swai, Andrew ^a   Mhalu, Fred ^a   Biberfeld, Gunnel ^b   Sandström, Eric ^c  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ABSENTEEISM; ADULT; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DEVELOPED COUNTRY; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; LUNG DISEASE; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MOUTH DISEASE; MYCOBACTERIUM TUBERCULOSIS; NEUROLOGIC DISEASE; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; SERODIAGNOSIS; SKIN DISEASE; T LYMPHOCYTE; TANZANIA; TUBERCULOSIS; UROGENITAL TRACT DISEASE; VARICELLA ZOSTER VIRUS; WEIGHT REDUCTION; WORKER;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; OCCUPATIONS; TANZANIA;

EID: 4143052457     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410016249     Document Type: Article

References (39)

1. Bacchetti P, Moss A. Incubation period of AIDS in San Fransisco. Nature 1989; 338: 251-3.
2. Rutherford GW, Lifson AR, Hessol NA, Darrow WW, O'Malley PM, Buchbinder SP, et al. Course of HIV-1 in a cohort of homosexual and bisexual men: 11 - y follow-up study. Br Med J 1990; 301: 1183-8.
3. Hendriks JCM, Medley GF, van Griensven GJP, Coutinho RA, Heisterkamp SH, van Druten HAM. The treatment-free incubation period of AIDS in a cohort of homosexual men. AIDS 1993; 7: 231-9.
4. Colebunders R, Ryder R, Francis H, Nekwei W, Bahwe Y, Lebughe I, et al. Seroconversion rate, mortality and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire. J Infect Dis 1991; 164: 450-6.
5. Anzala O, Nagalkerke NJ, Bwayo JJ, Holton D, Moses S, Ngugi EN, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995; 171: 686-9.
6. Crampin AC, Floyd S, Glynn JR, Sibande F, Mulawa D, Nyondo A, et al. Long-term follow up of HIV positive and HIV negative individuals in rural Malawi. AIDS 2002; 16: 1545-50.
7. Morgan D, Malamba SS, Orem J, Mayanja B, Okongo M, Whitworth JAG. Survival by AIDS defining condition in rural Uganda. Sex Transm Infect 2000; 76: 193-7.
8. Mann JM, Bila K, Colebunders RL, Kalemba K, Khonde N, Bosenge N, et al. Natural history of human immunodeficiency virus infection in Zaire. Lancet 1986; 265: 707-9.
9. Leroy V, Msellati P, Lepage P, Batungwanayo J, Hitimana D, Taelman H, et al. Four y of natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 1988 -1993. J Acquir Immune Defic Syndr 1995; 9: 415-21.
10. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, et al. Reduced rate of disease development after HIV-2 infection compared with HIV-1. Science 1994; 265: 1587-90.
11. Morgan D, Mahe C, Mayanja B, Okongo M, Lubega R, Whitworth AG. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002; 16: 597-603.
12. Moss AR, Bacchetti P, Osmond D, Krampf W, Chaisson RE, Stites D, et al. Seropositivity for HIV and the development of AIDS and AIDS related conditions: 3-y follow-up of the San Francisco General Hospital cohort. Br Med J Clin Res 1988; 296: 745-50.
13. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high risk patients as the initial manifestation of AIDS. N Eng J Med 1984; 311: 354-8.
14. Greenspan D, Greenspan JS, Hearst NG, Pan LZ, Conant MA, Abrams DI, et al. Relation of oral hairy leukoplakia to infection with human immunodeficiency virus and the risk of developing AIDS. J Infect Dis 1987; 155: 475-81.
15. Melbye M, Grossman RJ, Goedert JJ, Eyster ME, Biggar RJ. Risk of AIDS after herpes zoster. Lancet 1987; 1: 728-31.
16. + lymphocyte counts in HIV-infected subjects without AIDS. AIDS 1991; 5: 1209-15.
17. 3. J Infect Dis 1994; 170: 1284-7.
18. Munoz A, Schrager L, Bacellar H, Speizer I, Vermund SH, Detels R, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the multicentre AIDS cohort study: 1995-1991. Am J Epidemiol 1993; 137: 423-38.
19. Pierce M, Crampton S, Henry D, Heifets L, Lamarca A, Montecalvo M, Wormser GP, Jablonowski H, Jemsek J, Cynamon M, Yangco BG, Notario G, Craft JC. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Eng J Med 1996; 335: 384-91.
20. Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, Nielsen TL, van de Graaf Y, et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Eng J Med 1992; 327: 1836-41.
21. Yeni PG, Hammer SM, Carpenter CCJ, Cooper DA, Fischl MA, Gatell JM, et al. Antiretroviral treatment for adult HIV infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel. JAMA 2002; 288: 222-35.
22. Centers for Disease Control and Prevention. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents: recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR 2002; 51:(No. RR-7) 1-55.
23. Centers for Disease Control and Prevention. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. 2001.
24. World Health Organization. Scaling up antiretroviral therapy in resource-limited settings. Guidelines for a public health approach. Available at http://who.int/HIV_AIDS (accessed June 17, 2003).
25. World Health Organization. WHO Global Programme on AIDS. Proposed WHO criteria for interpretation of results from Western blot assay for HIV-1, HIV-2, and HTLV-HTLV-II. Wkly Epid Record 1990; 37; 281-3.
26. + T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR 1997; 46: 1-29.
27. + T-lymphocytes among HIV-1 infected adults in Dar es Salaam, Tanzania. AIDS 2004; 18: 433-8.
28. Sandstrom E, Urassa W, Bakari M, Swai A, Mhalu F, Biberfeld G, Pallangyo K. Percentage CD4 T-lymphocytes can be used to estimate CD4 T-lymphocyte counts in HIV-1 infected subjects in sub-Saharan Africa. Int J Std AIDS 2003; 14: 547-51.
29. 4 T-lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illness. The Adult and Adolescent Spectrum of HIV disease Project Group. Arch Intern Med 1995; 155: 1537-42.
30. Brambilla AM, Castagna A, Nocita B, Hasson H, Boeri E, Veglia F, Lazzarin A. Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections. J Acquir Immune Defic Syndr 2001; 27: 44-8.
31. Farizo KM, Buehler JW, Chamberland ME, Whyte BM, Froelicher ES, Hopkins SG, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United states. JAMA 1992; 267: 1798-805.
32. Rinke de Wit TF, Tsegaye A, Wolday D, Hailu B, Aklilu M, Sanders E, et al. Primary HIV-1 subtype C infection in Ethiopia. J Acquir Immune Defic Syndr 2002; 30: 463-70.
33. Niu MT, Stein DS, Schittman SM. Primary human immunodeficiency virus type-1 infection: review of pathogenesis and early treatment intervention in human and animal retrovirus infections. J Infect Dis 1993; 168: 1490-501.
34. Keet IP, Krijnen P, Koot M, Lange JM, Miedema F, Goudsmit J, Coutinho RA. Predictors of rapid progression to AIDS in HIV seroconverters. AIDS 1993; 7: 51-7.
35. Pedersen C, Lindhardt B, Jensen BL, Lauritzen E, Gerstoft J, Dickmeiss E, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. Br Med J 1989; 288: 154-7.
36. Morgan D, Mahe C, Mayanja B, Whitworth JAG. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. Br Med J 2002; 324: 192-6.
37. Ghate MV, Mehendale SM, Mahajan BA, Yadav R, Brahme RG, Divekar AD, Paranjape RS. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune. The National Medical Journal of India 2000; 13: 183-6.
38. Carre N, Deveau C, Belanger F, Boufassa F, Persoz A, Jadand C, et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994; 8: 797-802.
39. Rosenberg PS, Goedert JJ, Biggar RJ. Effect of age seroconversion on the natural AIDS incubation distribution. Multicentre Haemophilia Cohort Study and the International Registry of Seroconverters. AIDS 1994; 8: 803-10.